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DEPARTMENT OF HEALTH AND HUMAN SERVICES 

CENTERS FOR DISEASE CONTROL AND PREVENTION 

ADVISORY COMMITTEE ON 

CHILDHOOD LEAD POISONING PREVENTION 

October 14-15, 2003 

Atlanta, Georgia 

Minutes of the Meeting 
The Department of Health and Human Services (HHS) and the Centers for Disease 
Control and Prevention (CDC) convened a meeting of the Advisory Committee on 
Childhood Lead Poisoning Prevention (ACCLPP). The proceedings were held on 
October 14-15, 2003 at the Embassy Suites at Olympic Centennial Park Hotel in 
Atlanta, Georgia. 
Dr. Carla Campbell, the ACCLPP Chair, called the meeting to order at 8:44 a.m. on 
October 14, 2003. She welcomed the attendees to the proceedings and particularly 
recognized the diligent efforts and valuable contributions of five ACCLPP members 
whose terms have expired: Ms. Cushing Dolbeare, Ms. Anne Guthrie-Wengrovitz, Dr. 
Birt Harvey, Ms. Amy Murphy and Dr. Michael Shannon. Dr. Campbell opened the floor 
for introductions; the following individuals were present to contribute to the discussion. 
ACCLPP Members Dr. Kimberly Thompson 
Dr. Carla Campbell, Chair 
Dr. William Banner, Jr. Designated Federal Official 
Dr. Helen Binns Dr. Mary Jean Brown, 
Dr. Walter Handy, Jr. Executive Secretary 
Dr. Jessica Leighton 
Dr. Tracey Lynn Ex-Officio/Liaison Members 
Dr. Sergio Piomelli Mr. Matt Ammon (HUD) 
Dr. Catherine Slota-Varma Mr. Byron Bailey (HRSA) 
Dr. Kevin Stephens, Sr. Mr. Steve Hays (AIHA) 
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Dr. Ezatollah Keyvan (CSTE) 

Ms. Patricia McLaine (NCHH) 

Mr. Ronald Morony (EPA) 

Dr. Patricia Nolan (APHA) 

Dr. Routt Reigart II (AAP) 

Dr. George Rodgers (AAPC) 

Dr. Walter Rogan (NIH) 

Mr. Robert Roscoe (NIOSH) 

CDC Representatives 

Dr. Henry Falk, NCEH/ATSDR Director 

Ms. Crystal Gresham 

Ms. Janet Henry 

Dr. David Homa 

Mr. Jeff Jarrett 

Ms. Helen Kuykendall 

Dr. Tom Matte 

Ms. Susan McClure 

Dr. Patrick Meehan 

Dr. Pamela Meyer 

Mr. Timothy Morta 

Ms. Cathy Ramadei 
Ms. Kathy Skipper 
Presenters and Guests 
Dr. Craig Boreiko (International Lead 
Zinc Research Organization, Inc.) 
Estelina Dallett, Esq. (Dickstein, 
Shapiro, Morin & Oshinsky) 
Reuben Koolyk, Esq. (Arnold & Porter) 
Ms. Mary Ellen O'Connell 
(National Academy of Sciences) 
Jane Luxton, Esq. (King & Spalding) 
Mr. Don Ryan 
(Alliance for Healthy Homes) 
Mr. Russell Riggs 
(National Association of Realtors) 
Dr. Ian von Lindern (TerraGraphics 
Environmental Engineering) 
Dr. Michael Weitzman 
(University of Rochester) 
Update on CDC Activities 
National Center for Environmental Health (NCEH). Dr. Patrick Meehan was recently 
appointed as the Deputy Director for Program of NCEH/Agency for Toxic Substances 
and Disease Registry (ATSDR). He provided a status report of the newly consolidated 
agency. This action was taken because NCEH and ATSDR were two separate HHS 
agencies that conducted similar and often overlapping environmental public health 
activities at state and local levels. The consolidation will result in one federal 
environmental public health agency that is more streamlined, effective and efficient. 
However, the agencies' programmatic functions have not been merged and names 
have not been changed at this point. Only Congress has the authority to remove legal 
restrictions to take these actions. 
On the one hand, NCEH has a broad mandate that covers all aspects of environmental 
public health. On the other hand, ATSDR is authorized and funded by the Superfund 
legislation with a Congressional mandate that is limited to conducting Superfund 
activities. To overcome legal barriers in the short term, the NCEH and ATSDR Offices 
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of the Directors and administrative functions were formally integrated in August 2003. 
Dr. Henry Falk was appointed as the NCEH/ATSDR Director; Mr. Robert Delaney and 
Mr. Peter McCumiskey were appointed as the Deputy Director for Management for 
NCEH and ATSDR, respectively. 
In addition to merging leadership and administrative functions, other changes will also 
be implemented to consolidate the agencies. The transition team is represented by 
staff from both agencies to ensure that the NCEH/ATSDR Office of the Director is 
organized and structured in the most efficient manner. Many of the -250 positions in 
the NCEH and ATSDR Offices of the Directors will be reassigned to program areas 
within divisions. Financial, personnel, information systems, global health and other 
infrastructures will be consolidated into single offices. The Futures Initiative will be 
replicated in the consolidated NCEH/ATSDR agency. 
The Futures Initiative is a major strategic planning activity currently underway 
throughout CDC to develop innovative concepts and approaches in the areas of global 
health, research, systems and customers. Strategies created for these four domains 
will be used to guide CDC's decision-making process over the next few years. Overall, 
the NCEHI ATSDR consolidated agency must demonstrate success in integrating two 
Offices of the Directors, streamlining administrative functions and effectively 
collaborating while maintaining separate mandates and appropriations. This 
accomplishment will generate strong political will for Congress to examine the 
Superfund law and completely merge NCEH and ATSDR in the future. 
Dr. Meehan was pleased to report that the HHS Secretary and CDC Director/ATSDR 
Administrator fully support the consolidation. Most notably, NCEH and ATSDR have 
already built a solid track record in successfully completing joint projects. With respect 
to ACCLPP, the consolidated agency will not significantly impact the NCEH Childhood 
Lead POisoning Prevention Program because the activity has a separate line item of 
-$40 million. The consolidation will also have no effect on the three NCEH divisions 
and four ATSDR divisions. 
Lead Poisoning Prevention Branch (lPPB). Dr. Mary Jean Brown is the new ACClPP 
Executive Secretary. Her status report covered the following areas. First, the case 
management document developed by ACCLPP was published and is currently being 
evaluated. For the pre-evaluation, state and local partners are attending training 
sessions to describe the impact of the case management document and training 
sessions on local practices. For the post-evaluation, training session attendees will be 
contacted three to six months after participation to determine whether changes in 
behavior persisted due to the case management document and training sessions. 
Feedback about the training sessions has been overwhelmingly positive to date. lPPB 
expects to update ACClPP on the evaluation outcomes during the next meeting. 
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Second, LPPB forwarded ACCLPP's strategy for targeted screening of Medicaid 
children to the Center for Medicare and Medicaid Services (CMS) for review and 
comment. CMS has not yet returned the revised document to LPPB; the strategy will be 
submitted to the HHS Secretary after the CDC clearance process is complete. 
ACCLPP focused on this issue in response to findings by the Government Accounting 
Office. The data showed that <60% of children enrolled in Medicaid were screened for 
blood lead levels (BLLs). However, >83% of children with BLLs ~20 j.Jg/dL are enrolled 
in Medicaid. Third, "Surveillance for Elevated Blood Lead Levels (EBLLs) Among 
Children in the United States from 1997-2001" was published in the Morbidity and 
Mortality Weekly Report (MMWR). The report represents a monumental effort and is an 
essential step in LPPB's ability to target resources to areas most in need and evaluate 
progress. 
The surveillance report reflects blood lead tests reported to LPPB only; all children who 
were tested from 1997-2001 are not captured. Nevertheless, LPPB believes the states 
reporting data represent 90%-95% of the child population in the United States. Over 
this time period, the surveillance report shows that the population of children 1-5 years 
of age increased from 20 million to 22 million; the number of BLL tests reported to LPPB 
increased from 1.7 million to 2.5 million; and the number of children confirmed with 
EBLLs in all categories decreased from 130,000 to 75,000. LPPB will continue to focus 
on this issue. CDC's new electronic reporting system will improve data reporting and 
strengthen LPPB's capacity to develop and distribute surveillance reports of BLL tests 
on a more routine basis. 
Fourth, LPPB funded 42 new cooperative agreements in July 2003 for childhood lead 
poisoning prevention programs (CLPPPs) at state and local levels. The program 
announcement required applicants to demonstrate capacity in several areas: identify 
and provide services for children who are lead poisoned or at high risk for lead 
poisoning; refocus some activities to primary prevention; develop childhood lead 
poisoning elimination plans; create approaches to evaluate childhood lead poisoning 
activities throughout the jurisdiction; and establish strategic partnerships with agencies 
to promote lead hazard reduction. LPPB has already met with nine grantees to ensure 
that strong collaborations are developed with local and state partners in housing, 
banking and finance, pediatrics and public health to advance elimination plans. 
LPPB has also asked grantees to consider mechanisms to address lead exposure in 
pregnant women from a variety of sources, such as renovation, occupation, traditional 
medicine and ceramics. In addition to states, Chicago, Los Angeles, New York City, 
Detroit, Philadelphia and Washington, DC were funded as well. Applicants were 
selected based on need and expertise. Dr. Brown concluded her update by 
emphasizing for the record LPPB's deep appreciation to the five ACCLPP members 
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whose terms have expired. Plaques will be distributed to Ms. Dolbeare, Ms. Guthrie­
Wengrovitz, Dr. Harvey, Ms. Murphy and Dr. Shannon. ACClPP applauded the 
dedicated service of the former members to the nation's children and their commitment 
to preventing childhood lead poisoning. 
ACClPP was extremely pleased that lPPB has established a process to collect 
surveillance data of EBlls on a more consistent basis. The system is an excellent first 
step, but several suggestions were made to improve future surveillance reports. Dr. 
Campbell and Ms. Mclaine encouraged lPPB to distinguish between states with 
universal and targeted screening and also to focus on screening of children 1-2 years of 
age. Dr. Banner stressed the need to focus on children on the "tail" of the distribution of 
Blls because those children are disproportionately affected. He also urged NCEHI 
ATSDR to encourage ClPPPs to collaborate with poison control centers. Dr. Rodgers 
raised the possibility of making the surveillance database of EBlls available to the 
public. 
Dr. Brown and Dr. Pamela Meyer of lPPB followed up on ACClPP's comments. The 
surveillance report of EBlls serves as a baseline in collecting and analyzing data and 
strategically using the information to evaluate and target programs. lPPB received 
requests from Congress to produce the initial document, but future surveillance reports 
will present more sophisticated analyses and there should be more complete and 
comparable data. Significant progress has already been made since the surveillance 
data were collected in 2001. Most notably, many more states are now reporting all Bll 
tests instead of EBll tests only. 
However, the surveillance report of EBlls should not be viewed as a state-based 
replication of the National Health And Nutrition Examination Surveys (NHANES). 
NHANES is still the best tool to analyze children's Blls at the national level. lPPB will 
attempt to develop a surveillance database of EBlls for public use in the future, but 
CDC is developing a data release policy and eventually would like to create a public use 
database. lPPB is already making efforts to ensure that NCEH/ATSDR explores 
partnerships between ClPPPs and poison control centers. 
Ms. Patricia Mclaine, the PPW Chair, conveyed that most programs have been 
interested in primary prevention for several years and have incorporated many elements 
of primary prevention in local activities. Because the only effective treatment of EBlls 
is prevention, ACClPP established a workgroup to develop a primary prevention 
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framework. This tool will be used to assist in achieving the national goal to eliminate 
childhood lead poisoning by 2010. During the March 2003 meeting, ACCLPP 
conditionally approved the primary prevention document pending refinement by a 
professional editor and final approval by the full membership. 
ACCLPP agreed that the primary prevention document would be a stand-alone report 
primarily focused on housing and targeted to CLPPPs, state and local health 
departments, and partner organizations. The document may serve as a companion 
report to CDC's 1997 screening guidelines. During previous meetings, ACCLPP made 
several recommendations to PPW to strengthen the document. The term "primary 
prevention" should be included and the target audience should be identified at the 
beginning of the document. The references should be improved and a glossary of 
terms should be prepared. An appendix with a list of resources and links to other 
sources should be added. 
Comments made by Dr. David Jacobs of the U.S. Department of Housing and Urban 
Development (HUD) should be incorporated in the preface. "Lead-safe" should be 
clearly defined and the scope and breadth of the role of CLPPPs should be 
characterized. PPW held a meeting on March 19, 2003 and took several actions to 
address ACCLPP's recommendations. The document was thoroughly reviewed and 
edited by CDC and Mr. Ellis Goldman of HUD. PPW dedicated the document to Mr. 
Goldman who recently passed away. A glossary and appendix were developed with 
URLs, links to other resources, and contact information for public and private agencies. 
Comments made by Dr. Jacobs during the March 2003 meeting were transcribed 
verbatim and included in the document. 
Lead-safe was clearly defined as "units that were treated and cleared at a point in time." 
"Initiate," "catalyze," "orchestrate," "coordinate," "collaborate," "participate" and similar 
terms were incorporated throughout the document to clarify the role of CLPPPS. 
CLPPPS are expected to provide public health leadership in primary prevention, but the 
programs will not always play a leading role in this effort. The references were 
improved and will be reviewed again before the document is finalized. The revised 
document was distributed for review and comment to PPW members and CLPPPs in 
California, Minnesota, North Carolina, Ohio, Oregon and Philadelphia. 
Overall, the CLPPPs found the document to be very well written and extremely useful in 
advancing toward primary prevention of childhood lead poisoning. However, several 
CLPPPS recommended that concrete examples of primary prevention strategies be 
included in the document; additional program guidance be provided; and funding be 
increased at state and local levels. Comments submitted by PPW members have been 
incorporated and the document is nearly finished at this point. After ACCLPP takes a 
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vote, PPW will include additional comments submitted by members and review the 
revised document with the ACCLPP Chair and LPPB staff. 
The document will then be submitted for CDC clearance, review and approval of final 
changes. PPW will finalize the distribution strategy for the document, but a tentative 
plan has already been developed. The document will be immediately posted online 
after the CDC clearance process is complete. Approximately 5,000 copies will be 
initially printed and mailed to CLPPPs, state and local health departments, lead 
programs funded by HUD and the U.S. Environmental Protection Agency (EPA), and 
HUD and EPA regional offices. Information about the primary prevention document will 
also be circulated bye-mail to raise awareness and secure media coverage in the 
American Journal of Public Health and similar publications. 
ACCLPP made several suggestions to strengthen the primary prevention document. 
• 	 Hold a press conference to publicize the document and strongly 
encourage legislators to allocate funding for primary prevention. 
• 	 Highlight research opportunities for primary prevention. 
• 	 Emphasize the need for programs to collect economic data on primary 
prevention costs and cost savings. 
• 	 Make efforts to further clarify the roles of CLPPPs and health departments 
in primary prevention. For example, recommend that an interagency 
workgroup be established with leaders to designate responsibilities. 
• 	 Replace "preventing lead poisoning" with "preventing lead exposure" in the 
title. 
• 	 Explicitly state that secondary prevention is important; other lead sources 
should be investigated for an individual child; and population-based 
changes need to occur based on local conditions. 
• 	 List examples of best practices that could be formatted into a "childhood 
lead poisoning prevention handout" and distributed to expectant mothers 
at prenatal classes. 
• 	 Encourage CLPPPs to collaborate with non-traditional partners in the 
primary prevention effort. For example, testing agencies could incorporate 
language about lead poisoning into licensing examinations, certification 
tests or continuing medical education courses for contractors, physicians 
or medical students. Retail outlets could distribute information to 
consumers about lead-based paint and other hazards in the home. 
• 	 Add data about primary prevention cost savings to obtain support from 
legislators. 
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Expanding the focus to include lead hazards not related to housing was discussed, but 
it was agreed that primary prevention through housing was to remain the primary focus 
of this document. 
Dr. Lynn and several other members did not receive a copy of the primary prevention 
document prior to the meeting and were unable to provide PPW with meaningful input. 
ACCLPP agreed to table its vote until the following day to give the members time to 
review the document overnight. References for the document and the list of unsafe 
work practices would be distributed for the members to review as well. ACCLPP also 
agreed that the primary prevention document should maintain its focus on housing; 
workgroups will be established in the future to address other sources of lead exposure. 
Ms. McLaine confirmed that efforts are underway to address many of ACCLPP's 
suggestions. For example, the Alliance for Healthy Homes is currently conducting a 
project that contains several innovative strategies and concrete examples of primary 
prevention. Retail outlets throughout the country will soon begin putting labels on paint 
cans and distributing pamphlets about lead-based paint to consumers. Several lead 
programs have already established partnerships with local hardware stores and home 
improvement chains. Ms. McLaine also acknowledged that many of ACCLPP's 
recommendations were made at previous meetings and are captured in the current 
version of the document. During the overnight review, she encouraged the members to 
ensure that PPW fully and appropriately addressed these issues. 
Dr. Campbell announced that in May 2003, she met with the Federal Interagency Lead­
Based Paint Task Force and summarized the primary prevention document. ACCLPP 
will distribute the final document to members of this group and request assistance in 
advancing the primary prevention effort. Dr. Brown urged ACCLPP to feel free to take a 
vote on the following day because the CDC clearance process will not substantially 
change the document. However, ACCLPP will be notified if CDC proposes major 
revisions. 
Review ofEvidence for Effects at BLLs <10Ilg/dL 
Update by the Workgroup. Dr. Michael Weitzman is a former ACCLPP member and the 
Workgroup Chair. The other workgroup members are Drs. David Bellinger, Carla 
Campbell, Birt Harvey, Betsy Lozoff, Patrick Parsons, David Savitz, Joel Schwartz and 
Kimberly Thompson. Drs. David Homa and Tom Matte of CDC provide the workgroup 
with extensive technical support. The members represent expertise in pediatrics, 
neuropsychological assessment, lead and non-lead environmental epidemiology, 
ACClPP Meeting Minutes Page 8 October 14-15, 2003 
biostatistics, quantitative risk assessment and laboratory science. ACCLPP established 
the workgroup in March 2002 with the following charge. The members were asked to 
review existing evidence for adverse effects of lead exposure and toxicity on children at 
levels below those currently defined as "elevated" by CDC or at levels <10 1J9/dL. The 
draft document of the workgroup's findings was distributed to ACCLPP prior to the 
meeting. 
Dr. Weitzman reviewed the charge to the workgroup and its approach in responding to 
the charge. The charge to the workgroup was to review the existing evidence for 
adverse effects of lead exposure and toxicity on children at very low BLLs and to focus 
on effects at BLLs of 10 1J9/dL and below. To fulfill the charge, the workgroup set out to 
answer two questions: whether available evidence supports negative associations 
between children's BLLs and health in the range of <10 1J9/dL and whether observed 
associations are likely to represent a causal effect of lead on health. 
Dr. Weitzman then summarized the background section of the workgroup report, which 
discusses the context within which this review was conducted. No threshold has been 
identified to date for harmful effects of lead. A meta-analysis of cross-sectional studies 
conducted by the World Health Organization (WHO) shows several wide confidence 
intervals and a decrement of 2.5 10 points when a BLL increases from 10 1J9/dL to 20 
1J9/dL. Prospective cohort studies that examined the association between change in 10 
and a BLL increase from 10 1J9/dL to 20 1J9/dL showed similar results as the WHO 
findings. At the same time that health effects have been identified at lower BLLs, 
population BLLs have fallen. The most recent estimates show that the median BLL for 
children <6 years of age in the United States is -2.2 IJg/dL and 2.2% of children have 
BLLs >10 1J9/dL. 
Despite the decrease in mean BLL and the percentage of children with BLLs >10 IJg/dL, 
large social and geographic disparities still perSist. In addition, the typical body burden 
of lead today is estimated to be two orders of magnitude above estimated pre-industrial 
levels. To assess whether associations between BLLs and health in the range of <10 
IJg/dL are likely to represent causal relationships, the workgroup considered criteria 
conventionally used by epidemiologists for this purpose, which are stated in a 1964 
Surgeon General's report on smoking and health. These criteria include consistency of 
findings across epidemiologic studies; strength of the association defined by relative risk 
or odd ratio; a temporal relationship; and coherence of the biological plausibility and 
mechanism of action. 
Dr. Weitzman noted that ACCLPP rather than the workgroup will determine the impact 
the findings will have on policy and practice. Thus, policy issues ACCLPP might 
consider, but which were not considered by the workgroup, include the feasibility of 
measuring and classifying BLLs in categories <10 1J9/dL in the laboratory; the 
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availability of effective interventions for BLLs <10 1J9/dL; the advantages and 
disadvantages of lowering the BLL threshold below 10 1J9/dL; the impact of diverting 
resources currently targeted to children with BLLs >10 1J9/dL; and policy options at both 
individual and population levels. 
The workgroup also established criteria to define and include "relevant studies" in the 
review of evidence. Studies were required to be published in English and measure 
BLLs with graphite furnace atomic absorption spectrometry (GFAAS) or anodic stripping 
voltametry. Studies that assessed IQ or general cognitive index (GCI) as an outcome 
had to analyze the association between children's BLLs and IQ or GCI and were 
included whether or not analyses specific to BLLs <10 IJg/dL were conducted. Studies 
that did not evaluate IQ or GCI as an outcome had to analyze the association between 
children's BLL <10 1J9/dL and another health outcome. The workgroup also accepted 
studies with a formal or informal assessment using non-linear modeling; linear modeling 
of ~95% of children with BLLs <10 1J9/dL; a statistical comparison of ~2 subgroups with 
BLLs <10 1J9/dL; or a graphical display of results permitting visual assessment of the 
relationship between outcome and BLLs in the range of <10 IJg/dL. 
Dr. Weitzman then noted that few studies had conducted analyses specific to BLLs <10 
1J9/dL and health. The workgroup decided studies in which IQ or Gel was the outcome 
would be included even if they did not include such directly relevant analyses. This 
approach was taken to determine whether slopes of the BLL-IQ relation became more 
horizontal as the mean BLL of 10 1J9/dL was approached. This finding would suggest a 
no observed effect level. If slopes did not tend to diminish with mean BLLs approaching 
10 IJg/dL and below or became steeper, a continuation of the BLL-IQ association at 
lower BLLs would be supported. 
ATSDR's 1999 toxicological profile for lead served as the workgroup's initial data source 
to identify references. Several online searches of data collected from 1990-2003 were 
also conducted to supplement and update original references. Structured abstracts 
obtained from the literature search were reviewed to locate relevant articles. The 
workgroup identified 25 epidemiologic papers on IQ or proxy measures involving 16 
different populations. Most papers showed an association consistent with an adverse 
effect on cognitive function and that adjusting for potential confounders attenuated, but 
did not eliminate the association. The exceptions to these results were a Kosovo study 
in which adjusted findings were stronger than unadjusted findings and a Cleveland 
study in which the association was eliminated at low BLLs with adjustments for social 
class and other exposures. 
The workgroup examined the relation of study population mean BLL to BLL-IQ slope in 
two groups of published analyses: those in which BLL was measured at <24 months of 
age and those in which BLL was measured at age 4 years and older. In neither group 
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of results did regression slopes tend to diminish as the mean BLL decreased. In two 
studies with sufficient power to analyze the relationship between lower BLLs and 
cognition among children whose BLLs never exceeded 1 0 ~g/dL, the BLL-IQ slope was 
greater than among all children enrolled. The workgroup reviewed research that 
evaluated non-neurocognitive outcomes using the Wide Ranging Achievement Test for 
math and reading scores; the WISC-R block design and digit span subscales; tapping 
speed for sensorimotor function; and visual function. The workgroup also reviewed 
studies relating BLLs to growth, pubertal development and dental caries. 
Based on its extensive and comprehensive review of the evidence, the workgroup 
concluded that both direct and indirect data support a negative association between 
children's health, in particular cognitive function, and BLLs in the range of <10 ~g/dL. 
Dr. Weitzman then reviewed factors the workgroup considered in judging whether the 
observed associations are likely to be causal. Low BLLs affect fundamental 
biochemical processes in animal and in vitro models unaffected by confounding factors. 
Animal research demonstrates effects in experimental studies that are consistent with 
those found in humans with BLLs of 1 0 ~g/dL, but primate data on BLLs <1 0 ~g/dL are 
limited. The workgroup concluded that effects at BLLs <1 0 ~g/dL are plausible, but a 
mechanism of action has not been clearly established, especially that would account for 
the steeper slope at low BLLs. 
The workgroup considered the impact that the age trend in BLLs, which tend to peak 
between 15 months and 3 years of age in most populations and the tendency of BLLs to 
correlate within individuals, might have on observed results. The NHANES cross­
sectional studies reviewed involved school-aged children and did not measure BLLs at 
the peak point. Therefore, effects associated with BLLs <10 ~g/dL may be falsely 
attributed to effects due to BLLs >1 0 ~g/dL occurring at an earlier age. However, the 
uncertainty with the NHANES study does not apply to the 2003 Bellinger or Canfield 
papers. In these two studies, multiple BLLs were obtained at the pOint in which the 
highest BLLs were seen in children. The workgroup concluded that neither the age 
trend in BLLs nor errors in BLL measurement can fully explain observed associations 
between BLL and adverse health indicators in children. 
The workgroup considered what impact methods of neuropsychologic assessment 
might have had on study results. The workgroup concluded that because examiners 
were blinded to BLLs in neurobehavioral assessments of cohorts in well-documented 
studies, biased neuropsychologic assessment is unlikely to explain the observed 
results. The workgroup considered whether confounding by unmeasured factors or 
factors measured with error might explain the study results. Of particular concern is the 
potential for residual confounding by social environment, which is strongly related to IQ 
and lead exposure, but difficult to measure precisely. In addition, some factors, such as 
maternal depression, were not measured in any study. The workgroup concluded that 
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some degree of residual confounding cannot be ruled out and, if present, might explain 
the troubling finding of the slope of the relationship between effects and Blls <10 IJg/dl 
being steeper than at Blls >10 1J9/dL. 
The workgroup also considered other potential confounding factors. Most studies the 
workgroup reviewed had limited or no gold standard measures of iron deficiency to 
determine whether observed associations were due to iron deficiency. However, the 
studies that controlled for iron did not weaken the trend between lead and IQ. 
Measures used to analyze the relationship between cognition and prenatal or passive 
tobacco exposure were weak in most studies. The dose and critical period when 
exposure occurred were not quantified. These limitations add further to the uncertainty 
in estimating the impact of Blls on children's health. 
Another alternative explanation considered by the workgroup is that mouthing behavior 
might be a cause of more lead ingestion and a marker for delayed neurodevelopment. 
No direct evidence has been collected to date to support the hypothesis. In the Port 
Pirie cohort, early measures of cognitive function were not association with later BlL. 
The workgroup concluded that other than cognition, sufficient data have not been 
collected on any endpoint to make a definitive statement about a causal relationship 
between an outcome and BlL. The overall weight of evidence favors an inverse 
association between Blls <10 IJg/dl and children's health, particularly neurocognition. 
The workgroup determined that the association between Blls <10 1J9/dl and children's 
cognitive function is more likely than not causal, at least in part. However, limitations, 
especially residual confounding by socioeconomic status (SES), cause uncertainties 
about the size and shape of effects. Current data do not support labeling children with 
Blls <10 1J9/dl as "lead poisoned." Specific research projects should be undertaken to 
address gaps in the evidence base, such as analyses to assess residual confounding 
factors in observational studies in different settings; intervention trials to prevent, 
diminish or reduce Blls <10 IJg/dl; and animal studies of mechanisms and dose­
response. Dr. Weitzman acknowledged the diligent efforts of Drs. Homa and Matte for 
collecting, reviewing and compiling an enormous amount of data. 
Dr. Campbell opened the floor for the members to weigh in on the workgroup's draft 
report. She explained that the input will be used to refine the final document; the report 
will eventually be distributed as an ACClPP product. Dr. Piomelli pointed out that the 
workgroup relied on the Bellinger and Canfield papers, but these studies use an 
unacceptable methodology. For example, a child with a current Bll of 8 1J9/dl who had 
a Bll of 12 1J9/dl two months ago would have the same health effects. As a result, the 
exposure would be mis-classified. Moreover, the slope being stronger at <10 IJg/dl 
rather than at >10 IJg/dl is absurd. Dr. Piomelli wholeheartedly agreed with the 
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workgroup's conclusions, but the findings should not be based on problematic data. He 
noted that he outlined his concerns in a letter and distributed the document to ACClPP. 
Dr. Banner was surprised that the workgroup included the Kosovo study in its review 
because the exposure sources, cultures and ethnic backgrounds of the cohorts were 
extremely different. He questioned the workgroup's approach in calculating power that 
is necessary to obtain and control for adequate confounding factors. He cited two 
studies for the workgroup to consider while revising the document. The lozoff study in 
Costa Rica should be reviewed to analyze the impact of paternal intelligence and "iron 
insufficiency" on children's outcomes. The Shannon paper published in Clinical 
Toxicology should be reviewed to examine pervasive developmental delay and 
persistent exposure to lead as a result of mouthing behavior. 
Dr. Banner also recommended that one reference in the workgroup report be corrected. 
The 2003 Bellinger paper is actually a letter to the editor that was not peer reviewed and 
is based on older published data. He noted that some of the workgroup's findings are 
different than the conclusions outlined in the Bellinger manuscript. He advised the 
workgroup to clearly explain the inconsistency in the report. Dr. lynn agreed that 
additional research is critically needed on effects at Blls <10 1J9/dl to remove 
confounding SES variables. For example, nutritional aspects directly related to brain 
development and learning ability were not captured in the Canfield paper. 
Dr. Binns advised ACClPP to focus on next steps in this process. First, a mechanism 
should be developed to widely distribute the report in an appropriate venue. Information 
on current knowledge as well as uncertainties about effects at Blls <10 1J9/dl is 
critically needed by front-line providers. Second, the workgroup will soon finalize the 
document and complete its charge. A new workgroup should be established to explore 
policy implications that will be used to drive decision-making. Dr. Rodgers questioned 
the workgroup's rationale to not use the term "lead poisoned." 
Dr. Reigart viewed the report as a useful synthesis of complex data that should be 
published independent of ACClPP. He encouraged the members to refrain from 
significantly altering the document. The information in the report should be separated 
from policy implications to prevent childhood lead pOisoning. The document will be 
extremely useful to pediatricians who routinely advise parents about environmental 
hazards at relatively low levels that may adversely affect children. Ms. Mclaine was 
pleased that the workgroup report emphasizes the importance of primary prevention 
and risk assessment. 
Dr. Campbell reiterated the need to perform additional research on effects from Blls 
<10 1J9/dL. The number of solid studies on this issue is small and the number of 
children in the studies the workgroup reviewed is limited. She raised the possibility of 
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duplicating existing studies to more closely examine residual confounding factors and 
other research needs identified by the workgroup. Dr. Campbell conveyed that solid 
data may provide more certainty about the association between children's health and 
BLLs <10 ~g/dL. Dr. Stephens indicated that the cost benefit of lowering BLLs <10 
~g/dL is an additional research need. These data would greatly improve the current 
medical literature. 
Dr. Kevyan inquired whether the workgroup analyzed the original data in an effort to 
minimize ambiguity in the studies. Dr. Leighton made suggestions to refine the 
workgroup report. A discussion should be included on the magnitude of effects 
compared to other potential effects. The difference between individual effects on a child 
and population effects should be more strongly emphasized. The conclusions should 
be revised to match questions the workgroup attempted to answer on the basis of its 
charge. Dr. Campbell directed ACCLPP to submit written comments on the workgroup 
report to LPPB. After LPPB receives marked-up drafts from members, the revisions will 
be forwarded to the workgroup to review and address. The revised document will be 
discussed at the next ACCLPP meeting before being finalized. ACCLPP commended 
the workgroup for developing an excellent report. 
Drs. Matte and Weitzman responded to several of ACCLPP's questions and comments. 
The workgroup will share and discuss Dr. Piomelli's letter with other epidemiologists to 
address his concerns. The multi-variate models in the studies had adequate power to 
detect a statistical association based on home score, maternal IQ and other covariates 
measured. However, the workgroup plans to further refine the report to more accurately 
balance the uncertainties and conclusions. The members realize that tobacco, iron 
status and other residual confounding factors were not adequately measured in the 
observational studies. Nevertheless, the workgroup is fairly confident that major 
potential variables with an influence on cognitive function and a strong relationship to 
lead were identified. The available data did not allow the workgroup to reach definitive 
conclusions for ACCLPP to address all policy issues. 
ACCLPP will need to describe the cost benefit of lowering BLLs <10 ~g/dL because this 
issue is beyond the workgroup's charge. The workgroup was also not directed to 
analyze existing data. However, a consortium of investigators that conducted the lead 
cohort studies is currently performing a pooled re-analysis of the original data to more 
closely examine the shape of the dose-response relationship. The workgroup 
recommended that a statistical method used for air pollution studies be applied to the 
pooled re-analysis of the lead cohort studies. This tool is useful in addressing 
confounding factors in multi-center studies. The workgroup agreed that applying the 
term "lead poisoned" is inappropriate. Evidence has not been collected to date that 
every child with a certain BLL will be adversely affected. 
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Policy Options. Dr. Brown conveyed that the <10 workgroup report and policy options 
will be complimentary, but not necessarily linked. Both sets of information will be useful 
to CDC's state and local partners and the broader public health community. LPPB has 
held several discussions about policy options related to the <10 workgroup report and 
will maintain its strong commitment to children with EBLLs. Most notably, health effects 
ranging from reduced IQ to death become more pronounced as lead exposure and 
BLLs increase. LPPB realizes that several important issues must be addressed to 
provide services to children with EBLLs. For example, ACCLPP's guidelines for case 
management of children with EBLLs can be accessed on the CDC web site. 
Many studies have documented the failure of clinical or educational interventions to 
either reduce BLLs in children with at least moderate lead exposure or decrease 
developmental effects associated with EBLLs. State-based data indicate that in many 
cases, several years are required to reduce children's BLLs after levels become 
elevated. In response to this evidence, CDC lowered the level of concern from 40 1J9/dL 
in the 1970s to 10 1J9/dL in the 1990s. At this time, LPPB does not believe the level of 
concern for an individual child should be lowered from 10 1J9/dL. Although compelling 
evidence has been produced demonstrating that adverse health effects can occur at 
BLLs <10 1J9/dL, several important factors must also be considered. 
No effective clinical or public health interventions have been identified to lower BLLs. 
The unavoidable error associated with laboratory testing is too great to ensure that 
children are properly classified. No data have been collected demonstrating a threshold 
below which no adverse effects are found. Children at highest risk are not appropriately 
screened at the present time. While implementing the High Intensity Targeted 
Screening (HITS) project in Chicago in 2001, for example, LPPB learned that only 39% 
of young children in a low-income neighborhood had ever received a blood lead test. 
Testing and providing follow-up services to children with BLLs <10 IJg/dL will deflect 
resources from children living in high-risk communities. 
Communities with the largest percentage of children with BLLs >24 1J9/dL also have the 
greatest proportion of children with BLLs that are lower, but still well above the national 
average. These reasons emphasize the critical need to advance primary prevention 
and target communities where the risk for exposure is highest. Primary prevention in 
these communities will most likely benefit all high-risk children. In a primary prevention 
strategy, the first essential element is to focus on lead-based paint in housing as the 
most important source of lead for young children. An intervention would be conducted 
before the child's BLL is elevated by identifying high-risk communities and incorporating 
lead poisoning prevention activities into health and community services that reach 
families at high risk for lead poisoning. 
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The infrastructure currently exists to identify high-risk housing. Most notably, units built 
before 1950 have been located and specific addresses of units that have repeatedly 
poisoned children are known to local officials in many areas. In Detroit, Michigan, 657 
addresses accounted for nearly 1,500 children with BLLs ~20 ~g/dL identified in the last 
ten years. In Louisville, Kentucky, <0.3% of all housing in the community housed 35% 
of children with BLLs ~10 ~g/dL in the last five years. The remediation of high-risk 
housing should be the highest priority in primary prevention. Partners in housing, 
banking and code enforcement should be strongly urged to become engaged in this 
effort. Primary prevention can be linked to secondary prevention activities that are 
currently being conducted by most state and local agencies. 
For example, low-cost or free training sessions on lead-safe work practices for workers 
are available. However, caution must be taken to ensure that the necessary 
requirements and enforcement of lead-safe work practices exist before paint in these 
units is disturbed. Making efforts to advance primary prevention is also optimal at this 
time because more federal support of housing remediation is now available than in the 
past. Targeting resources to housing that is most likely to expose children to lead paint 
and lead contaminated house dust or soil is imperative. Another primary prevention 
strategy is to make a market for housing that has been de-leaded. 
Several approaches can also be taken for primary prevention of other lead sources. 
Communities where cultural practices and traditional medicines place families at risk 
can be identified. Current and new non-essential uses of lead in toys, jewelry, food 
utensils, and cosmetics can be controlled or eliminated. Lead poisoning prevention 
activities can be incorporated into health and community services that reach families at 
high risk for exposure. To meet the Healthy 2010 objective to eliminate childhood lead 
poisoning, the public/private partnership must be strengthened among clinicians, public 
health providers and housing agencies. 
Private and public health care providers as well as environmental health professionals 
can advocate for children and foster lead exposure prevention by facilitating the 
implementation of primary prevention recommendations in state and local communities. 
Active participation by these groups will provide necessary expertise and leadership to 
accomplish primary prevention goals. Pediatricians and other health care providers 
should include education about measures to prevent or reduce EBLLs as part of 
standard anticipatory guidance during routine well child visits. Recommendations to 
assist providers in this area can be found in Chapter 6 of the ACCLPP case 
management guidelines. 
LPPB is already taking action in the primary prevention effort. The focus of the CLPPP 
program announcement was changed to allocate funding to areas with the highest risk 
children. Grantees are required to improve data management and reporting and must 
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also develop childhood lead pOisoning elimination plans at state and local levels. The 
plans must focus on targeted screening to high-risk populations, primary prevention, 
and community-based partnerships beyond the medical and public health fields. LPPB 
is also strengthening strategic alliances with existing partners, including the Women, 
Infants and Children (WIC) program, HUD, immunization services, Medicaid and the 
Department of Education. 
LPPB has signed a memorandum of understanding with the Low Income Home Energy 
Assistance Program. This agreement will ensure that the weatherization community 
has knowledge of lead poisoning, is aware of ongoing activities, and trains workers in 
lead-safe work practices. LPPB plans to enhance partnerships with local housing code 
enforcement agencies as well. LPPB acknowledges that elimination of lead exposure in 
young children is the most important outcome of a successful primary prevention 
strategy. This goal can be measured at both national and local levels. NHANES data 
can be used to analyze BLLs of children based on a national representative sample and 
demonstrate the nation's progress in meeting the 2010 objective. State-based 
surveillance data of children's EBLLs can be used to develop programs that identify and 
respond to local areas with the highest need. CDC will continue to conduct both 
activities. LPPB is confident that lead poisoning can be resolved and the 2010 objective 
can be met. 
Some ACCLPP members were divided on LPPB's approach to maintain the focus on 
children with BLLs >10 jJg/dL. On the one hand, Dr. Rodgers clarified that interventions 
are currently available to lower a child's BLL to <10 jJg/dL. The public will believe that 
BLLs <10 jJg/dL are safe if CDC takes no public health actions. The workgroup's review 
of the evidence demonstrates that BLLs <10 jJg/dL are a concern. Dr. Rodgers 
indicated that because the BLL standard of 10 jJg/dL is global, maintaining this 
threshold would be a disservice to the entire world. He added that similar to 10 jJg/dL 
being established as the standard in 1991, a goal for a lower BLL can be set as well. 
Mr. Hays also cautioned LPPB against informing the public that BLLs <10 jJg/dL are 
safe. 
On the other hand, Drs. Thompson and Lynn completely agreed with LPPB's strategy to 
maintain the focus on children with BLLs >10 jJg/dL. The current evidence does not 
identify a "safe" threshold for a lower BLL. Dr. Nolan clarified that the threshold can be 
addressed by reviewing the health disparities elimination model and establishing a 
standard based on success. For example, if 4 jJg/dL was the lowest BLL achieved in a 
community, this level could be established as the mean. Dr. Rogan raised the 
possibility of changing the goal from eliminating childhood lead poisoning to eliminating 
26% of lead hazardous units in the United States that house children <6 years of age. 
ACCLPP Meeting Minutes Page 17 October 14-15, 2003 
Dr. Binns was in favor of lowering the standard of testing children's BLLs from 24 
months to 18 months of age. This approach may allow providers to detect peak BLLs 
earlier. Dr. Matte did not understand the rationale for emphasizing blood lead tests at a 
certain age. Compelling data have been collected during prenatal visits, children's 
births and high-risk pregnancies to show that housing is the most important factor in 
EBLLs. This evidence should be utilized to bridge the gap between housing-based 
strategies and blood lead tests. Dr. Matte added that a true primary prevention strategy 
would focus on children at risk for lead poisoning and their housing before the children 
are poisoned. As a result, interventions should occur during pregnancy or at the child's 
birth rather than after a blood lead measurement is taken. 
Dr. Stephens agreed with Dr. Matte's suggestion to intervene at the earliest possible 
time. Most notably, obstetricians could inform expectant parents who plan to renovate a 
room for a new baby about the need to examine other areas of the home and remove 
peeling paint or other sources of lead. Dr. Slota-Varma also saw the need for LPPB to 
develop partnerships with obstetricians. The success of the "Back to Sleep" program to 
reduce sudden infant death syndrome and the car seat campaign to decrease fatal 
automobile accidents involving infants is largely due to informed parents. Obstetricians 
can replicate these models by educating expectant and new parents about lead 
poisoning and screening. 
Mr. Morony expressed concern that CDC interprets the 2010 objective as "virtual 
elimination of <1 %." Using this calculation, -100,000 children in the United States 
would still be lead poisoned. Because the vast majority of these children will be in 
minority populations. EPA and agencies at state and local levels will find the goal to be 
unacceptable and withhold support for or investment in CDC's elimination program. Dr. 
Campbell was in favor of ACCLPP making recommendations to public health providers 
and the general public about mechanisms to improve blood lead screening. The need 
to continue case management interventions for previously identified children should be 
strongly emphasized as well. 
Ms. McLaine was pleased that LPPB's strategy compliments primary prevention 
activities currently underway throughout the country. Homes with lead-poisoned 
children are being remediated and the public health infrastructure is being used to target 
at-risk families living in older housing. These models have been ongoing for quite some 
time in Milwaukee, Rhode Island and other local programs. Dr. Leighton advised LPPB 
to clearly define and explicitly state the <10 recommendations. For example, primary 
prevention activities should be targeted to at-risk children and the BLL should be set at 
a threshold to perform the best interventions. She supported combining the CDC 
guidelines and primary prevention document to provide a concise and conceptual 
framework. 
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Several members suggested additional partners LPPB should consider while building 
strategic alliances: building code enforcement agencies, building maintenance 
personnel, insurance agencies, realtors, testing agencies and certification programs, the 
Consumer Product Safety Commission, the Food and Drug Administration, and 
remediation workers. Dr. Campbell proposed that ACCLPP formalize these 
deliberations in a written draft. The document could then be distributed to members for 
review and comment prior to the next meeting. 
Dr. Meehan conveyed that an ad hoc group would serve as a better mechanism to 
address policy and practice considerations and implications of the < 10 workgroup 
report. The group could specifically focus on the public health response to this issue 
and draft appropriate guidance to provide to clinicians. LPPB staff could be designated 
to support the group in developing a draft document. Dr. Thompson noted that in 
addition to an ad hoc group, guidance to clinicians should also be considered as a 
tremendous research opportunity. She made a motion for ACCLPP to establish a 
Policy Options Ad Hoc Group; Dr. Banner seconded the motion. The motion 
unanimously passed with no further discussion. 
Dr. Campbell charged the group with formalizing ACCLPP's comments about policy 
options. LPPB staff will provide technical support in developing a draft document. The 
group's report will be presented to the full ACCLPP for review and comment. Dr. 
Weitzman has already expressed an interest in serving on the Policy Options Group. 
ACCLPP members who are also willing to serve should inform Dr. Campbell. 
Drs. Brown and Meehan followed up on ACCLPP's comments. LPPB's targeted 
strategy should not be misinterpreted to mean that BLLs <10 jJg/dL are safe. Instead, 
LPPB is taking a population-based approach and recommending a public health action 
to target resources to entirely remove lead from children's environments through 
primary prevention. This approach will be more effective in reaching the 2010 objective 
than continuing to screen, identify children ages 0-6 years, and offer interventions. 
Retesting children and educating parents are the only interventions currently 
recommended for BLLs in the range of 10-14 jJg/dL, but only a minimal amount of 
evidence has been gathered to date demonstrating that these actions make a 
difference. 
The data reviewed by the workgroup provided no justification to establish a new BLL 
threshold <10 jJg/dL. Moreover, mistakes were made when this standard was set in 
1991. Nevertheless, LPPB realizes that more explicit language should be included in 
the <10 workgroup report. For example, the document should urge providers to perform 
follow-up testing on children 24 months of age. The report should also specifically point 
out that lead in the body at any level is not good. LPPB also recognizes that 
collaborative efforts should be undertaken with federal partners to establish health-
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based thresholds for lead in dust, house paint and other media. LPPB will make strong 
efforts in the future to build alliances with obstetricians to ensure that expectant mothers 
are aware of the dangers of scraping old paint. 
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Building Blocks for Primary Prevention 
Mr. Don Ryan, Executive Director of the Alliance for Healthy Homes (Alliance), 
announced that CDC awarded a two-year contract to the Alliance from September 30, 
2002-September 29, 2004 to develop building blocks for primary prevention. The 
project is specifically focused on housing and lead-based paint hazards in housing, but 
the model will be replicated for other sources if the primary prevention building blocks 
demonstrate success. The project can also compliment ACCLPP's primary prevention 
document by describing concrete examples. The Alliance realizes that the effort for 
local and state departments to shift to primary prevent will be tremendous. 
Of the 98 million units in the U.S. housing stock, 60 million are lead-free, 13 million with 
lead-based paint are in lead-safe condition, 25 million pose one or more lead hazards, 
and -30,000 of these are home to a child identified with a BLL >20 1J9/dL. A "unit" is 
defined as a single-dwelling home or apartment. Despite these challenges, however, 
considerable progress has been made over the last five years in primary prevention at 
state and local levels. Building blocks are structured to identify successful strategies of 
individual programs and provide other programs with an extensive list of specific 
primary prevention examples. A building block serves as an innovative or promising 
strategy, tactic, tool, resource or programmatic change to protect children prior to 
exposure to lead and other environmental health hazards in the home. State and local 
health officials and CLPPP directors serve as the primary target audience for building 
blocks. 
The Alliance selected seven areas for the initial building blocks: financing and 
subsidies; lead safety and healthy homes standards; code enforcement and other 
systems; capacity building for lead safety; collaborations, partnerships and incentives; 
targeting strategies; and mechanisms to build awareness and public support. Criteria 
the Alliance established to select building blocks include consistency with the principles 
of public health; sensitivity to the economics of affordable housing; a potential for broad­
scale impact; a reasonable possibility of implementation; and a real promise for 
reducing hazards in high-risk housing. The Alliance recently submitted to CDC a draft 
outline summarizing the 75 most promising building blocks identified to date; the 
document was distributed to ACCLPP as well. The building blocks will eventually be 
expanded to a two-page template containing specific information and will also be 
designed as an easily searchable web-based system. 
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The Alliance took several actions to identify candidate building blocks. Input was 
solicited from internal staff, CDC, ACCLPP, lead grantees, and health departments at 
state and local levels. The published literature and other data were reviewed. A call for 
nominations was widely announced to health departments, housing agencies and 
community-based organizations. Model building blocks are described as follows. 
For financing and subsidies, Los Angeles tenants demanded a rent increase of $1 per 
month to create a special fund for code enforcement. Los Angeles County hired 70 
additional code inspectors and committed to inspecting all rental properties once every 
three years. New Jersey and other jurisdictions are using the Community Reinvestment 
Act to collaborate with banks that receive credit for conducting community service 
activities. 
For lead safety and healthy homes standards, New Orleans, San Francisco and other 
cities have banned unsafe work practices, while California and Rhode Island are making 
lead hazards a violation of the housing code. For code enforcement and other systems, 
Illinois is training code inspectors to identify lead hazards and pursue enforcement. 
Milwaukee, Philadelphia and San Francisco are abating lead hazards when owners fail 
to act and imposing a lien on the property to recover costs. For capacity building for 
lead safety, Chicago is holding free lead-safe work practice training sessions on a 
regular basis. This action is being taken as part of an agreement between Attorney 
Generals and the National Paint and Coding Association to sponsor 150 training 
sessions per year. California and Indiana are adding lead safety to weatherization 
training courses. 
For collaborations, partnerships and incentives, Maine is partnering with child care 
facilities to ensure lead safety for young children. For targeting strategies, Ohio, 
Vermont and other states are capitalizing on home nursing visits to target prevention 
services and make necessary referrals to health or housing agencies. 
For mechanisms to build awareness and public support, Philadelphia analyzed and 
publicized data on EBLLs in the districts of city council members to facilitate improved 
policies. This initiative resulted in the establishment of a new lead court and a 
substantial reduction in the backlog of lead cases. Community groups throughout the 
country are being trained in the basics of lead hazard identification and screening to 
document high-risk housing units. 
Digital photographs of properties are being presented in court to visually confirm the 
presence of lead hazards. Toxic tours have been organized in several communities to 
raise public awareness of high-risk housing units. 
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In addition to the building blocks project, the Alliance has also developed the "primary 
prevention taste test." Readers are asked to review the alphabetized list and cross out 
all items that do not qualify as primary prevention. The Alliance is requesting that 
ACCLPP review the 75 building blocks summarized in the draft outline and provide input 
to LPPB by October 31, 2003. The Alliance will then revise the document based on 
ACCLPP's comments and resubmit the second draft to CDC by the end of November 
2003. The outline will be widely distributed to LPPB grantees that are developing 
childhood lead poisoning elimination plans. 
Dr. Campbell raised the possibility of extending the Alliance contract beyond September 
29,2004 because other innovative building blocks may be proposed after this time. Dr. 
Thompson was pleased that the Alliance is collecting economic data to highlight the 
cost of the interventions. This information will be extremely important when other 
programs are making decisions to replicate a particular activity. Although the project 
focuses on innovative and promising tools, Dr. Thompson urged the Alliance to also 
gather information on building blocks that were not selected. Distributing lessons 
learned will prevent other programs from repeating previous errors. 
Dr. Stephens added that specific categories of building blocks will also assist programs 
in the decision-making process, such as projects in urban versus rural areas and state 
versus local jurisdictions. He was interested in ACCLPP making an effort to identify 
building blocks that can be implemented at the national level. Ms. McLaine pointed out 
that the primary prevention literature is minimal because <20% of programs evaluate 
individual activities. She asked LPPB to engage research organizations to ensure the 
building blocks are formally evaluated. 
Dr. Leighton emphasized the need to coordinate ACCLPP's primary prevention 
document and the Alliance building blocks to ensure consistent messages are being 
delivered. She added that the building blocks document should explicitly inform 
programs about the need for local data to drive interventions. Because many programs 
will be overwhelmed by 75 building blocks, this guidance will assist in the decision­
making process. Dr. Binns mentioned that primary prevention data should be 
incorporated in the building blocks document, such as prenatal projects in st. Louis or 
home cleaning studies. 
Mr. Ryan clarified that the Alliance reviewed the published literature, but evaluating the 
data to identify successes and failures is beyond the scope of the contact. However, 
the Alliance used the published literature to establish criteria and select the building 
blocks. Dr. Banner inquired about actions that will be taken for programs with no 
interest in developing or implementing building blocks since the previous primary 
prevention campaign failed. Dr. Brown replied that additional funding, attention and 
other resources now being targeted to primary prevention will most likely increase the 
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interest of programs in becoming actively engaged in this effort. Mr. Ammon 
underscored the need for CDC and HUD to closely collaborate in developing primary 
prevention strategic plans since many programs are grantees of both agencies. 
.. Ii 
Public Comment Period 
Ms. Estelina Dallett is an attorney at the law firm of Dickstein, Shapiro, Morin & 
Oshinsky in Washington, DC. She was pleased about the focus on primary prevention 
by LPPB, ACCLPP and the Alliance. She viewed the building blocks document as an 
outstanding collection of successful techniques and approaches. However, she recalled 
that a "reasonable possibility of implementation" was one of the factors for the Alliance 
to select a building block. In one model project summarized in the draft outline, two 
lawsuits were filed against lead pigment manufacturers. One trial resulted in a hung 
jury and the other lawsuit was entirely dismissed with prejudice. This building block did 
not demonstrate success and may be inappropriate to distribute to programs. 
Mr. Ryan urged LPPB to issue a cohesive public health response to maintaining the 
focus on children with BLLs ~1 0 ~g/dL. This activity should extend beyond primary 
prevention strategies, an ACCLPP statement or the Alliance building blocks. Instead, 
strong public health messages about lead should be delivered. "Level of concern" 
should be refined because the term indicates that CDC is not concerned about BLLs 
<1 0 ~g/dL. The national goal of lowering children's BLLs to <1 0 ~g/dL should be 
clarified since the geometric mean BLL of children 1-5 years of age is 2.2 ~g/dL. The 
use of national averages in the context of lead poisoning is no longer appropriate 
because some communities have a lead pOisoning prevalence rate of 30%. Overall, the 
national goal for lead poisoning should be achieved by closing disparities of race and 
income. 
Mr. Ryan conveyed that the failure of secondary prevention is another issue ACCLPP 
and LPPB should aggressively pursue. Lead hazards are not remediated in at least 
50% of units that are investigated and found to have children with EBLLs. Screening 
children's BLLs is pOintless if lead hazards in housing are not corrected. For units with 
lead hazards that are remediated, lead-safe work practices and clearance dust testing 
after paint repair are often not applied. 
Mr. Ryan distributed to ACCLPP an informal survey the Alliance administered to 42 
health departments about lead dust testing practices. The 40 respondents reported the 
foltowing results: 32 health departments use lead dust testing; 8 states use dust testing 
as a screening tool for both EBLLs and high-risk housing; and 9 states do not conduct 
clearance dust testing. The Alliance has recommended that a formal survey be 
administered with more precise questions to obtain specific information about clearance 
dust testing practices. Mr. Ryan encouraged ACCLPP to review the Rochester study on 
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the failure of programs to utilize clearance dust testing. The 31 units in the study all had 
astronomical levels of lead dust on at least one surface, but the units were soon 
enrolled in the HUD Lead Hazard Control Grants Program. 
Ms. Jane Luxton is an attorney at the law firm of King & Spalding in Washington, DC. 
She received confirmation from Dr. Brown that the public can send comments on the 
<10 workgroup report to LPPB. She suggested that LPPB consider Dr. Kathleen White, 
the Designated Federal Official of the EPA Science Advisory Board, as a resource in 
convening advisory committee conference calls pursuant to the rules of the Federal 
Advisory Committee Act (FACA). Ms. Luxton will send Dr. White's contact information 
to Dr. Brown bye-mail. 
Dr. Campbell announced that the meeting would reconvene at 8:00 a.m. on the 
following day instead of 8:30 a.m. as noted on the published agenda. The extra time 
will be used for ACCLPP to further discuss and vote on the primary prevention 
document. There being no further business or discussion, Dr. Campbell recessed the 
ACCLPP meeting at 5:20 p.m. on October 14, 2003. 
DlscU8IIlon and Vole on the Primary PI'8ventien Document 
Dr. Campbell reconvened the ACCLPP meeting at 8:05 a.m. on October 15, 2003 and 
opened the floor for the deliberations. Ms. McLaine announced that Dr. Binns offered to 
assist PPW in adding numbers and making other refinements to the primary prevention 
document references. She asked the members to provide suggestions on improving 
the secondary prevention language in the document because the text continues to be a 
problem for PPW. ACCLPP members made comments on the document as follows. 
• 	 Refine the "at-risk populations" definition in the glossary to clearly place 
the focus on children. Residence in pre-1978 housing that may contain 
lead-based paint hazards is defined as the risk to women of child-bearing 
age, but actual risks to this population are pica and immigrant status. Add 
"pregnant women" or "expectant parents;" include "potential children of 
women;" and delete "(especially those aged 1-2)" to ensure newborns are 
captured. Alternatively, maintain the focus on pregnant women. [Dr. 
Binns will rewrite the definition to reflect and clarify housing-based 
hazards that need to be corrected before the child is exposed to lead.] 
• 	 Change the first sentence on page 15 to "Lead adversely affects children's 
cognitive and behavioral development." 
• 	 Restructure Appendix 5 to be parallel to the "eight elements" text box. 
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• 	 Add "and potentially overall quality of life" to the last sentence of the 
second paragraph on page 15. 
• 	 Change the first sentence of the executive summary to "Lead continues to 
be one of the most significant environmental diseases among young 
children in the United States." 
• 	 Change the last sentence in the first paragraph of the executive summary 
to "housing-associated lead hazards." [Since "lead-based paint hazards" 
is a federal definition used by EPA and HUD, agreement was reached to 
add "in and around housing."] 
• 	 Change the title to Preventing Lead Exposure in Young Children or 
Preventing Lead Exposure and Lead Poisoning in Young Children. 
• 	 Incorporate language to emphasize the importance of lead reduction. 
• 	 Add a sentence at the end of the second paragraph in the executive 
summary stating that "targeted screening should remain a priority to 
identify children with EBLLs." 
• 	 Change the "risk assessment" definition in the glossary to "lead risk 
assessment." 
• 	 Incorporate a section on research needs to assist programs in applying 
the primary prevention document to actual practice. 
• 	 Acknowledge economic issues that may be important in implementing 
primary prevention strategies. 
• 	 Underscore the need to use local data in the executive summary. 
• 	 Provide guidance for programs to improve targeted and cost-effective 
screening. 
• 	 Move Appendix 5 into the recommendations section to eliminate 
redundancy and improve readability. [The text was moved from the 
document and placed into a separate appendix in response to ACCLPP's 
previous suggestion.] 
• 	 Acknowledge the existence of other lead sources and additional at-risk 
populations in the executive summary, but explicitly state that the 
document is focused on housing-based prevention interventions for 
children. 
• 	 Change "threshold" to "no observed effect level" on page 11. 
• 	 Delete the sentence "Reducing lead emissions ..." on page 11. 
• 	 Change the first sentence of the second paragraph on page 20 to 'The 
goal of targeting housing for primary prevention ... " 
• 	 Change the first sentence of the third paragraph in the executive summary 
to " ... for emphasizing primary prevention related to housing ..." 
• 	 Change the first sentence of the second paragraph on page 20 to "...by 
removing lead exposure sources posed by lead-based paint. .." 
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• 	 Clarify secondary prevention by changing the sentence in the second 
paragraph on page 17 to "...are subsequently employed to prevent 
repeated exposures due to lead-based paint housing hazards." 
• 	 Change the order of items in "a" and "b" in the first sentence on page 21 
under "Recommendations" to reflect the priority for preventing future lead 
exposure. 
ACCLPP was divided on whether a vote should now be taken on the primary prevention 
document. On the one hand, Dr. Thompson requested that PPW incorporate 
ACCLPP's comments into the current version. The final draft should then be presented 
to members before a vote is taken. Dr. Lynn added that ACCLPP's goal should be to 
produce and distribute the best product possible. On the other hand, Dr. Binns 
emphasized that the vote should not be tabled because state grantees are supposed to 
be using the primary prevention document now to develop elimination plans. She noted 
that ACCLPP's suggestions are fairly minor and can be addressed without further 
delays in finalizing the document. 
Drs. Brown and Campbell resolved this issue by directing ACCLPP to submit comments 
to LPPB no later than October 22, 2003 to be forwarded to Ms. McLaine. Comments 
submitted after this date will not be entertained. After the revised version is distributed 
to ACCLPP, the members will decide whether a conference call is needed to discuss 
the document further. The members will then vote to approve the document by either a 
conference call or e-mail. Dr. Banner made a motion to conditionally approve the 
primary prevention document pending incorporation of ACCLPP's comments; Dr. Handy 
seconded the motion. The motion unanimously passed with no further discussion. 
Natlona' Aceflemy ofBclencea (NAB) Study 
Ms. Mary Ellen O'Connell of NAS described an upcoming study entitled "Environmental 
Health Research in Housing and the Built Environment: Ethical Issues Involving 
Children and Families." The study is primarily funded by HUD and will be conducted in 
response to the Kennedy Krieger case in which researchers involved three groups in 
housing intervention research. Two families in the project filed a lawsuit because their 
children had EBLLs. The lower court in Maryland ruled in favor of the researchers, but 
the state appellate court stated that the lawsuit could be tried. The researchers were 
eventually exonerated, but the case caused tremendous concern among housing 
researchers and also raised awareness about the lack of guidance related to housing 
intervention research. 
ACCLPP Meeting Minutes Page 26 	 October 14-15, 2003 
The scope of the NAS study will compare issues related to housing intervention 
research and biomedical research. EXisting approaches to interventions will be 
explored. Characteristics of therapeutic versus non-therapeutic interventions will be 
defined to determine whether parents can provide consent for children to participate in 
non-therapeutic research if more than minimal risk is involved. Research challenges 
and ethical issues will be characterized. Ethical obligations to inform children and their 
parents will be analyzed. The process for researchers to intervene in housing-related 
health hazard interventions and protect study participants will be examined. The goals 
of the NAS study are to advance housing research and provide guidance to researchers 
conducting studies on housing-related health hazards. 
Phase I of the project is underway. The scope of the NAS study is being refined and 
potential committee members are being identified to provide input on the study. 
Feedback will be solicited from the Institute of Medicine, NAS, ACCLPP, the Board of 
Children, Youth and Families, and other groups. Efforts will be made to ensure that 
input is balanced in terms of geographic representation, age, gender and ethnicity. NA 
will seek expertise in the areas of public policy, law, bioethics, child development, 
Institutional Review Boards, housing intervention research, environmental health, 
research involving children, community-based research and environmental justice. 
In Phase II, NAS will hold five or six committee meetings during a 15- to 21-month 
period; obtain input from families, community activists and similar groups; and convene 
a public workshop for commissioned papers to be presented. The committee will then 
produce a consensus report summarizing relevant research and outlining 
recommendations for research and ethical guidance. The consensus report should be 
developed 21-24 months after the committee is formed. In Phase III, the committee 
report will be disseminated to external experts for review and comment and then 
repeatedly revised based on input. At this time, NAS is requesting ACCLPP's 
assistance in advancing the study. Ms. O'Connell distributed a summary of the NAS 
study with her contact information. She encouraged ACCLPP to forward to her the 
names of potential candidates who can serve as committee members or reviewers as 
well as suggestions to improve the study. She clarified that ACCLPP members are 
eligible to serve on the NAS committee. 
Dr. Banner reported that Oklahoma faced ethical barriers related to conducting research 
on the impact of environmental exposures among children in protective custody. He 
urged NAS to consider this issue while refining the scope of the study. Dr. Thompson 
suggested that experts in risk benefit analysis also be considered as NAS committee 
members or reviewers. The Center on Bioethics in the National Institutes of Health 
should be contacted since this agency is currently defining "minimal risk." She noted 
that the NAS study will be helpful to areas beyond environmental issues related to 
housing. Dr. Binns recommended that a staff member from the Office for Protection of 
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Human Subjects serve on the NAS committee. Ms. Mclaine and Dr. Campbell were 
pleased that NAS is undertaking the study. ACClPP previously recommended that a 
prnil30rt nn pJhi~ I i~C:I II3oC: rl3ol~t~rl to hn' , ~inn rpC:l3o~r~h h~ r noci" I30d 
Lead Exposure at Superfund Sites 
Dr. Ian von Lindem, of TerraGraphics Environmental Engineering (TGEE), described 
lead cleanup activities at the Bunker Hill/Coeur d'Alene Basin Superfund site in Idaho. 
In 1974, the lead smelter in this area operated without pollution controls for six months 
and poisoned -2,000 children who lived within five miles of the facility. At that time, the 
average Bll for preschool children in the area was nearly 70 ~g/dL. The mean Bll for 
children in the community was 40 ~g/dl after the smelter ceased operations 1981. 
A TSDR conducted research in 1983 demonstrating that lead problems associated with 
residual soil and dust contamination around the facility continued to persist. The study 
showed that 25% of children in the area had Blls >25 ~g/dL. 
In 2002, the mean Bll in the community significantly decreased to 2.5 ~g/dl; only 2% 
of children had Blls >10 jJg/dl; and 85% of children had Blls <5 ~g/dL. The Idaho 
Superfund site is 21 square miles and covers five communities with 7,500 residents. 
The community was designated as the nation's second largest Superfund site until 
2002. At one point during its operations, the smelter produced 33% of lead, 25% of zinc 
and 50% of silver in the country. The goal of the cleanup activities at the smelter is to 
transform the site into a world-class destination resort. This objective would never have 
been considered without ACClPP's legacy of solid public health contributions to the 
nation and CDC's implementation of the Bll standard of 10 IJg/dL. 
The dramatic reduction in children's Blls in the area required a comprehensive cleanup 
of the entire community by first demolishing the 365-acre industrial complex of 
buildings, machinery and waste piles. The waste was then buried in a 40-acre landfill. 
Over the last few years, >2 million tons of material were removed and deposited in a 
large waste repository at the complex. The original landfill was replaced with clean soil 
and the old waste facility will eventually be remediated with parking lots, golf courses 
and soccer fields. However, the residential soil cleanup of 85% of homes within a 21­
square mile radius had the most significant impact on Blls. One foot of topsoil was 
replaced with clean material; this activity has been ongoing for 12 years. 
In 1990, the Idaho Superfund site established a goal of lowering Blls to <10 IJgldl for 
95% of children in each community and having no children with Blls ~15 IJgldL. This 
objective would be accomplished by examining site-specific dose-response 
relationships and identifying soil and dust concentrations in the environment that would 
need to be achieved. Residential and commercial soils with lead concentrations >1,000 
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mg/kg were replaced with soils <100 mg/kg to achieve a mean level of <350 mg/kg 
throughout the community. Yard-wide averages were determined by taking 24-inch 
random samples every 500 square feet in the yard. 
The ultimate goal of the soil cleanup was to reduce house dust concentrations to <500 
mg/kg. The percentage of children with BLLs ~10 IJg/dL in the three major cities 
surrounding the community dramatically decreased from 1988-2002. These data show 
a strong relationship between EBLLs and contaminated yard soil. The Lead Health 
Intervention Program was developed in the community to obtain BLLs of all children 
through door-to-door surveys. Children with EBLLs received follow-up as 
recommended by CDC. On an annual basis, 75% of children with EBLLs were 
identified through school records. Of -800 at-risk children in the community 0-9 years 
of age, 400 participated each year in the program. The 50% participation rate was 
largely due to the $20 incentive paid to children. The program was discontinued in 2003 
since community goals were met in 2002. 
ATSDR conducted three neurodevelopmental studies on the cohort of children that had 
EBLLs in the 1970s. ATSDR recommended that a registry be established because 
attention deficit hyperactivity disorder, renal problems, hypertension and reproductive 
effects were detected. Due to lack of political will by the state of Idaho, the registry was 
not established. Montana gathered names of the impacted children in an effort to 
develop the Idaho registry, but funding for the activity was discontinued in the second 
year. Follow-up testing on the children was also not performed. Although the victims 
were compensated through settlements of private lawsuits, no government 
compensation was ever offered. ATSDR's data were published and are available to the 
public. 
The high participation rate was not replicated in 1,000 children in the 1,500-square mile 
area surrounding the community. Only 25% of this population was recruited for the BLL 
survey. Other activities were targeted toward primary prevention. Under the High-Risk 
Residential Program, units that housed a pregnant woman or children <9 years of age 
were cleaned. This intervention resulted in -200 homes per year being cleaned. 
Because the cleaning intervention of individual houses was not fully successful, 
geographic area cleanups were then performed to eliminate lead sources in parks, 
playgrounds, roadsides, the smelter and other common areas. Solid science was 
applied to implement these cleanup activities. 
Of all inorganic contaminants at Superfund sites, lead is found most frequently. Unlike 
most contaminants, lead has no reference dose or cancer slope values. A cleanup level 
of 500-1,000 ppm was established for lead in 1989. The Integrated Exposure Uptake 
Biokinetic Model was developed by EPA in 1994 and is required to be used at all sites 
to assess the impact of lead on children. The current BLL of 10 1J9/dL should be 
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considered as the gold standard when using formulas to determine cleanup limits at 
sites. The threshold should be applied at sites by examining all sources of lead to 
children, calculating the bioavailability of each source, and analyzing the integrated 
combination of intake to children. House dust is the source of most lead for young 
children. Measurements of BLLs, house dust and soils can be used to estimate a 
child's intake of lead. 
Data collected in the Idaho community showed a strong association between BLLs and 
estimated intake. Undertaking cleanup actions at Superfund sites is extremely 
expensive and can exceed tens of millions of dollars. The federal government and the 
Coeur d'Alene tribe filed a lawsuit against several mining companies to assess 
damages to natural resources. On September 3, 2003, the presiding judge ruled that 
the federal government and the mining companies shared responsibility for depositing 
contaminated material at the site. The damages portion of the trial will begin in May 
2004. 
EPA funds were allocated for NAS to investigate the scientific aspects of the Idaho 
community cleanup activities, particularly those apportioning risks for multiple sources, 
analyzing risks other than mining and smelting, and using the EPA model. The Coeur 
d'Alene tribe asked about the feasibility of safely resuming aboriginal practices in the 
Flood Plain River. The current lead level by ingestion is 25-30 IJg/day, but some tribal 
practices will result in an ingestion level of >1,000 IJg/day. Approximately 400-900 
years will be needed before lead concentrations in the area will decrease to the point of 
supporting aboriginal practices. To date, the federal government has allocated -$150­
200 million to the remediation of the Idaho Superfund site; industry has spent $50-$100 
million; and $359 million has been set aside for the record of decision for the 1,500­
square mile area. 
Mr. Hays emphasized the need for TGEE to clearly document in writing techniques that 
were used to clean up dust in houses. Dr. von Lindern clarified that the long-term plan 
is to remove contaminated soil and other sources which move lead into the home, but 
current efforts are being directed toward house paint. Special studies on cleaning the 
home interior have been conducted and are available to the public. TGEE recently 
received a HUD Healthy Homes grant to analyze different measurement techniques in 
both clean and unremediated areas in Idaho. 
Ms. McLaine pointed out that high soil lead levels are not restricted to Superfund sites. 
Contaminated soil levels of up to 5,000 ppm have been detected in many urban areas. 
She hoped the TGEE data would be used to more closely investigate the association 
between children's BLLs and soil lead levels on a wider basis. Dr. Banner suggested 
that a study of an Oklahoma town serve as a control group to the Idaho Superfund site 
for comparative purposes. The Oklahoma town is in the middle of the mining activity 
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and yards in the community have been remediated. However, no contaminated piles of 
material have been moved to date. 
Update on Intematlonal Lead Issues 
Dr. Falk reported that lead poisoning is a resurgent theme in discussions of children's 
environmental health issues. Various commissions, United Nations groups and other 
committees continually emphasize the importance of this topic. Lead is an area of 
interest internationally due to the success of the United States in reducing childhood 
lead poisoning. Average BLLs were previously between 20-25 1J9/dL in the United 
States, but the levels have dramatically decreased over time. Lead in gasoline and 
other sources continue to affect children worldwide. Risk factors in the developing 
world are very striking and multiple lead sources differ from those in the United States. 
For example, international industrial sites are frequently located near or in residential 
areas. Hot climates lead to more intense exposures to outdoor environments. Child 
labor is an important factor in lead exposure in several countries, such as battery 
recycling by children in India. Most countries have inadequate environmental and 
laboratory monitoring capacity, a lack of data, and poor tracking systems of lead use 
and consumption. Poor nutrition plays a significant role in enhancing children's lead 
toxicity. Knowledge and skills in toxic chemicals are limited among international 
physicians and care givers. Disease surveillance systems are typically non-existent or 
incomplete. Chelating agents are frequently unavailable for children with EBLLs. 
Protective safety equipment, technologies, industrial engineering controls and hygiene 
programs are limited or entirely absent. Regulations in many areas are inappropriate or 
have not been developed. Implementation of standards are inconsistent; inspections 
are rarely performed; and lengthy delays are usually associated with completing new 
measures. The U.S. infrastructure to address lead problems is extremely different than 
that of the developing world, but important advances have been made internationally. 
The hand-held used to BLL in 
a community. This technology allowed several international studies to be conducted. 
Lead in gasoline continues to be a priority for the World Bank, international non­
governmental organizations and other groups. Children'S BLLs are nearly three times 
higher in areas in Budapest with heavy traffic and exposure to leaded gasoline versus 
less congested areas in the suburbs. Improvements have been made in several 
countries due to aggressive efforts by international programs to remove lead in 
gasoline. Campaigns have been ongoing for the past 10-15 years in Asia, Latin 
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American and the Caribbean. Several studies have documented considerable 
reductions in children's BLLs in countries that have removed lead from gasoline. 
A CDC study in Bangladesh showed 87% of children had Blls >10 ~g/dl and 21% had 
BlLs >20 ~g/dL. The most significant risk factor for EBLls in the study was living in 
housing adjacent to the highway. Research in Indonesia showed that the mean air lead 
level of 0.35 along urban highways was much higher than in rural areas. However, 
levels were much greater in urban, commercial and industrial areas where products that 
contained lead were used. Although removing lead in gasoline will reduce mean levels, 
extremely high levels will still persist in areas of the world where lead is used industrially 
or for other purposes due to poor controls and weak infrastructures. Similar results 
were seen in a Jamaican study that showed a mean BLL of 14 ~g/dL in urban school 
children versus 9 ~g/dL in rural school children. In mining districts or other 
contaminated areas, however, the median BLL was 35 ~g/dL. 
CDC conducted a study of lead issues in Cairo to advise the Egyptian government on 
establishing a central laboratory. During this time, CDC also visited a village in Aswan, 
Egypt in response to abdominal discomfort and other symptoms among residents. The 
mean BLL was 92.1 ~g/dL in the hospitalized group and 79.9 ~g/dL in the non­
hospitalized group. Five family members had BLLs between 150-175 ~g/dL. A flour mill 
was identified as the source of EBLLs since lead in the grinding equipment used at the 
facility could be ground into flour and consumed by residents. Over the following year, 
Bllsin the Aswan village significantly decreased to 30-40 ~g/dl after use of the 
grinding tool was discontinued. Rural Egypt contains -8,000 similar flour mills. 
In a study in Ecuador, lead glaze was used on roofing and other construction materials. 
Because child labor was also used to build homes, Blls of children in the area ranged 
from 20-44 ~g/dL. However, several children had Blls > 70 ~g/dL. Since pottery is stHl 
made with lead glaze throughout Mexico, children in rural areas where ceramics are 
used have much higher BLLs. Several studies have been conducted on EBLLs as a 
result of battery recycling in Jamaica, the Dominican Republic, Manila and Gaza. The 
year-round warm climate in these areas contribute to prolonged and fairly extensive 
lead exposures to children. CDC conducted a study in Lima, Peru due to the country's 
effort to remove lead from gasoline and obtain baseline BLLs. Peru was previously the 
six largest exporter of lead ore. 
Average BLLs in Lima were <1 0 ~g/dL, but the mean was >20 ~g/dL in the suburb of 
Callao where mineral deposits were shipped. In areas closest to the Callao port, 
average BLLs were even higher at >40 ~g/dL. The extremely dry climate and dirt roads 
were significant contributors to EBLLs among local children. 
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CDC collaborated with a private foundation in India and other groups to test 20,000 
children in major cities in India. The percentage of children with BLLs >10 IJg/dL ranged 
from 40%-60%, while a smaller proportion had BLLs >20 1J9/dL. In New Delhi, 
contaminated air was believed to be the cause of lead poisoning, but the sources were 
probably unrelated to air. Lead in gasoline, battery recycling plants, lead smelters, lead­
based pigment in paint, printing presses, ceramic pottery glazes, cosmetics containing 
lead and folk medicines were identified as lead sources in India. 
Efforts were made in New Delhi to duplicate EPA air regulations, but this initiative was 
unsuccessful due to the infrastructure in India. These projects have led to a joint 
binational program between India and the United States to collaboratively address 
occupational and environmental health hazards in India. Lead will be one of the focus 
areas in the binational agreement. 
Although efforts to prevent and eliminate childhood lead poisoning in the United States 
should continue, significant problems in the developing world must be addressed as 
well. The World Bank, WHO and other international groups should broaden the focus 
from lead in gasoline to other sources that can potentially result in much higher BLLs. 
Dr. Campbell pointed out that ACCLPP previously sent a letter to the HHS Secretary 
recommending immigrant and foreign-born adopted children receive BLL screening. Dr. 
Lynn emphasized the need for ACCLPP to continue to outreach to international 
organizations that provide services to immigrants and refugees who settle in the United 
States. ACCLPP can play a significant role in educating these groups about lead 
hazards. Dr. Nolan added that the American Public Health Association is also focusing 
on global health. These issues include refugees and immigrants who settle in the 
United States with a prior lead burden; industrial and commercial strategies in the global 
economy; and the impact of micro-environments on lead absorption among children and 
adults. Duplicating U.S. interventions research in foreign countries is an extremely 
important mission that should be remain on CDC's agenda. 
Dr. Rodgers inquired about ATSDR's formal charge for international toxicology issues. 
Dr. Falk clarified that ATSDR has no mandate in this area. The Superfund legislation 
provides ATSDR funding and authority to conduct activities, but the program is 
completely domestic. ATSDR is extremely interested in translating and sharing its 
toxicological profiles, training materials and other documents with developing countries 
to provide guidance in evaluating hazardous waste sites, assessing toxic chemicals and 
addressing similar issues. Dr. Falk hopes international collaborative efforts will be 
formalized now that the U.S.llndia binational agreement has been signed. 
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New ACCLPP sua/"... 

Dr. Campbell opened the floor for members to describe issues ACCLPP should 
consider as new activities or future agenda items. For the first new business item, Dr. 
Piomelli asked ACCLPP to consider door-to-door screening. NHANES data show a 
decrease in the average BLL in the United States, but EBLLs still persist in some areas 
of the country. This finding was recently highlighted by the HITS project in Chicago. 
ACCLPP has a responsibility to urge the HHS Secretary to allocate funding for door-to­
door blood lead testing. CDC and local health departments have a responsibility to 
conduct door-to-door screening. ACCLPP cannot be an advisory group for childhood 
lead poisoning prevention if the members ignore children in high-risk communities and 
take no actions to conduct door-to-door screening. The majority of lead intoxicated 
children are poor, minority or immigrants who may never present to a health care 
provider. 
Dr. Brown was reluctant to return to the practice of door-to-door lead screening program 
for children. Since many of these children have no medical home, BLL testing will be 
virtually meaningless without determining immunization status, enrollment in WIC or 
receipt of other benefits. A holistic approach must be taken to identify children with 
EBLLs. The American Academy of Pediatrics (AAP), practicing pediatricians and the 
broader health care community should play a leading roJe in high-risk areas. CDC's 
responsibility would be to educate clinicians about improving blood lead screening 
practices and locating areas in need. ACCLPP's role would be to partner with CDC to 
inform providers about their obligation to screen patients. 
Dr. Campbell mentioned that the primary prevention document will be extremely helpful 
in addressing Dr. Piomelli's concerns. The guidance is focused on high-risk properties 
where children have been poisoned in the past and also on low-income children, 
pregnant women and other high-risk populations. ACCLPP previously developed and 
distributed a document with recommendations for public health authorities and health 
care providers to increase screening of Medicaid children. Dr. Banner cautioned CDC 
against identifying AAP as the leader in the holistic approach for blood lead screening. 
Of pediatricians in Oklahoma, <50% accept Medicaid-insured patients. Pediatricians in 
many other states also have no involvement in the care of high-risk children. 
Dr. Nolan pointed out that many clinicians do not administer blood lead tests because of 
poor information systems rather than a reluctance to screen. Unlike immunizations, 
medical records do not contain a history of lead tests performed on an individual child. 
Physicians throughout the country have expressed a great deal of interest in improving 
electronic information systems to strengthen quality of care. CDC should partner with 
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the Agency for Healthcare Research and Quality and other agencies engaged in this 
effort. Reimbursement, policies to incorporate blood lead test results into medical 
records and other critical issues will need to be addressed at the federal level. 
Dr. Binns agreed with Dr. Piomelli's comments about the need to highlight racial health 
disparities. ACCLPP should deliver messages to providers that communities in greatest 
need are being ignored. Intense efforts should be targeted to black and Hispanic 
children and old housing or lead prevalence rates should be matched to census data. 
However, Dr. Binns did not believe that door-to-door testing should be widely replicated. 
The HITS program was successful in Chicago, but the initiative will be expensive or 
inappropriate in other parts of the country. 
Dr. Slota-Varma noted that enrollment in WIC, Healthy Start, Head Start, urban day 
care centers and similar programs presents excellent opportunities for blood lead 
screening to capture more high-risk children. Dr. Thompson advised CDC to examine 
the federal commitment to children in the broader public health context. She also asked 
Dr. Piomelli to clearly outline his concerns and ideas for action in a proposal. The 
document can be used to facilitate ACCLPP's continued discussion on racial and 
economic health disparities. 
ACCLPP agreed to take several actions in response to Dr. Piomelli's remarks. LPPB 
and CMS will present a status report at a future meeting on changes that have been 
made in screening practices of Medicaid children since ACCLPP's guidance document 
was disseminated. An overview of screening strategies in general and input from LPPB 
grantees will be presented at a future meeting as well. Dr. Campbell and other 
interested members will closely collaborate with LPPB and CMS to identify mechanisms 
to improve medical services and other benefits for Medicaid-eligible children. For 
example, a "lead checklist" for Medicaid patients can be distributed to emergency room 
providers and CMS could reimburse emergency room departments for providing these 
services. 
For the second new business item, Dr. Thompson asked ACCLPP to consider issues 
related to ACCLPP's function, operation and process. One, an extensive discussion on 
the <10 workgroup report should be scheduled on the next meeting agenda. Two, draft 
documents should be distributed to ACCLPP for review at least two weeks prior to 
meetings. For example, many members were unable to provide PPW with meaningful 
input on the previous day because the primary prevention document was distributed 
during the meeting. Clear expectations and deadlines should also be established for 
ACCLPP to submit comments on drafts. 
Three, ACCLPP documents should be available for the public to provide feedback. 
Four, current ACCLPP documents should be reviewed to ensure that the new federal 
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requirements for the Information Quality Act are being met. Five, a data set of raw data 
from CDC funded studies should be accessible to the public after projects are 
completed. Six, workgroups should be chaired by ACCLPP members who have 
attended at least one meeting and will continue to serve through additional meetings. 
Seven, research needs in general, LPPB's research activities in particular, and an 
ACCLPP discussion on research should be scheduled on a future meeting agenda. For 
example, LPPB should consider funding another long-term cohort study to better 
understand children's BLLs <10 IJg/dL. Dr. Campbell clarified that the CDC Committee 
Management Office (CMO) does not require workgroups for any advisory committee to 
be chaired by members. However, at least two members must serve on a workgroup. 
For the third new business item, Dr. Binns asked ACCLPP to consider follow-up actions 
to ongoing workgroup activities. First, LPPB should develop measurable housing goals 
in accordance with Healthy People 2010. This approach will provide primary prevention 
targets that can be evaluated in the future. Second, ACCLPP should form a workgroup 
to address the at-risk population of pregnant women. To facilitate this discussion at the 
next meeting, Dr. Leighton could present a report on New York City's screening 
activities, findings and recommendations related to pregnant women. 
Third, ACCLPP should establish a clear process to address policy options for the <10 
workgroup report. Input from both pediatricians and the public health community should 
be captured in ACCLPP's response. Dr. Binns is willing to chair the Ad Hoc Policy 
Options Group. For the membership, she asked Dr. Slota-Varma to provide expertise 
as a front-line clinician and Dr. Reigart to provide the AAP perspective. Dr. Thompson's 
position was that the charge of the new Ad Hoc Policy Options Group established on 
the previous day should be limited to formalizing ACCLPP's deliberations in a draft 
report. The responsibility of identifying appropriate policies for children's BLLs <10 
IJg/dL should remain with the full ACCLPP. 
For the fourth new business item, Dr. Lynn asked ACCLPP to consider developing 
formal written policies for its operation and function; the document would then be 
circulated to all members. The guidelines should clearly list specific deadlines for the 
following activities: LPPB to distribute drafts to ACCLPP for review; ACCLPP to submit 
potential agenda items to the Chair; ACCLPP to submit comments on documents; and 
LPPB to provide members with travel arrangements for meetings. For the current 
meeting, some members did not receive travel arrangements until the day before they 
were scheduled to depart. 
Convening conference calls between meetings to improve ACCLPP's function should 
be outlined in the policy document as well. LPPB should confer with CMO to ensure 
that ACCLPP's operational guidelines are consistent with FACA. In response to Dr. 
Lynn's final comment, Dr. Brown confirmed that LPPB will renew ACCLPP's charter 
ACCLPP Meeting Minutes Page 36 October 14-15, 2003 
which is scheduled to expire at the end of October 2003. The new charter will be 
circulated to all members. Dr. Campbell asked ACCLPP to submit suggestions for 
future agenda items to her at least six weeks prior to a meeting. 
~- Public Comment Period 
Dr. Craig Boreiko, of the International Lead Zinc Research Organization (ILZRO), was 
dismayed by several international lead issues he asked ACCLPP to consider. 
Linguistically and culturally appropriate guidance materials to diagnose and treat lead 
intoxicated children are minimal. Case management strategies are not appreciated in 
the developing world and access to chelating agents is extremely difficult. Lead is not a 
priority at the international level because other issues are much more important from 
economic, cultural and social perspectives. 
ILZRO has been partnering with United Nations groups to address these problems, but 
developing countries are currently not structured to impact integrated solutions. Dr. 
Boreiko asked ACCLPP to identify other groups with a strong interest in international 
lead issues. Dr. Banner suggested that ILZRO contact the International Program on 
Chemical Safety (IPCS) because this group produces a wealth of linguistically 
appropriate information on lead chelators. Dr. Boreiko clarified that IPCS materials are 
useful from an academic perspective, but the documents are virtually useless in the field 
when efforts are being made to communicate risk reduction and child intervention 
strategies. 
Potential dates for the 2004 ACCLPP meetings will be distributed to the members within 
the next two weeks. There being no further business or discussion, Dr. Campbell 
adjourned the ACCLPP meeting at 12:02 p.m. on October 15, 2003. 
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I hereby certify that to the best of my 
knowledge, the foregoing Minutes of the 
proceedings are accurate and complete. 
~
Carla C. Campbell, M .., M.S. 
ACCLPP Chair 
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